Literature DB >> 10229270

Difference in response of NK cell activity in newborns and adult to IL-2, IL-12 and IL-15.

T Hoshina1, K Kida, M Ito.   

Abstract

The killing activity of cord blood mononuclear cells (cMNC) against cytomegalovirus (CMV)-uninfected and -infected fibroblasts was comparable to that of adult peripheral blood mononuclear cells (aPBMC). The killing activity of cMNC against K562 cells was significantly lower compared with that of aPBMC. Treatment of cMNC and aPBMC with interleukin-2 (IL-2), IL-12 or IL-15 significantly enhanced killing activity against K562 cells and CMV-uninfected and -infected cells. By comparison of cMNC with aPBMC, killing activity against the K562 cells of cMNC was augmented to the level of aPBMC when cultured with IL-2, IL-12 or IL-15. The killing activity of cMNC against CMV-uninfected and -infected fibroblasts did not increase to the level of adult PBMC by treatment with IL-2, IL-12 or IL-15. These data suggest that cord blood contains a functionally different NK cell subpopulation than that among adult NK cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229270     DOI: 10.1111/j.1348-0421.1999.tb02387.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  5 in total

1.  Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newborn.

Authors:  William J Muller; Cheryl A Jones; David M Koelle
Journal:  Curr Immunol Rev       Date:  2010

Review 2.  The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells.

Authors:  Michael R Verneris; Jeffrey S Miller
Journal:  Br J Haematol       Date:  2009-10       Impact factor: 6.998

3.  A Case of Acute Lymphocytic Leukaemia with t(3;13) and Central Nervous System Leukemia after Allogenic Cord Blood Transplantation.

Authors:  Xiaofan Li; Yaqun Hong; Jiafu Huang; Nainong Li
Journal:  Cell Med       Date:  2019-09-04

4.  Bovine neonate natural killer cells are fully functional and highly responsive to interleukin-15 and to NKp46 receptor stimulation.

Authors:  Jamila Elhmouzi-Younes; Anne K Storset; Preben Boysen; Fabrice Laurent; Francçoise Drouet
Journal:  Vet Res       Date:  2009-06-24       Impact factor: 3.683

5.  Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells.

Authors:  L Herrera; S Santos; M A Vesga; J Anguita; I Martin-Ruiz; T Carrascosa; M Juan; C Eguizabal
Journal:  Sci Rep       Date:  2019-12-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.